vigencell gout treatment
Scope
Date
~
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Waste management
BKT thrives as lone Korean wastewater treatment provider in US
South Korean water treatment provider Bukang Tech(BKT) on Wednesday said it earned a contract to build a wastewater treatment facility in the US sta...
Nov 18, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma's epilepsy treatment posts impressive growth in US
South Korean SK Biopharmaceuticals' epilepsy treatment Cenobamate has seen rapid growth on the US market.The company on Thursday said the medic...
Nov 11, 2022 (Gmt+09:00)
-
Companies
US water treatment juggernaut Culligan eyes Chungho Nais stake
Culligan, the biggest water treatment company in the United States, is set to become a major shareholder in South Korean water purifier rental firm ...
Nov 09, 2022 (Gmt+09:00)
-
Earnings
Kakao's Q3 profit drops 12% on games, data center construction
South Korea’s mobile platform giant Kakao Corp. announced its third-quarter earnings on Nov. 3, including quarterly operating profit of 150.3 ...
Nov 04, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Keppel completes Korean waste treatment firm takeover for $530 mn
Singapore-based Keppel Infrastructure completed the acquisition of South Korea’s leading waste management company EMK Co. for 760 billion won ...
Oct 20, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korea's LG Chem buys Nasdaq-listed biotech firm AVEO for $566 mn
South Korea’s chemicals giant LG Chem Ltd. announced on Oct. 18 that it will acquire AVEO Pharmaceuticals Inc., a Nasdaq-listed US biotech fir...
Oct 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
COVID-19
Ildong mulls seeking COVID-19 pill approval from Korea first
Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...
Jul 22, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Corporate investment
Samsung Eng. to invest in Vietnam for SE Asia water biz
Samsung Engineering Co. agreed to spend $41 million on Vietnam’s largest private water treatment company for the eco-friendly business in Sout...
Jun 30, 2022 (Gmt+09:00)
-
Healthcare
CHA Healthcare buys major Australian fertility center
South Korea’s medical center operator CHA Healthcare Co. said on Monday it has acquired the management rights of Fertility Specialists of West...
Jun 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost acquires Canada’s OmniaBio for CDMO business
Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...
May 31, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SK Ecoplant buys e-waste recycling firm for $1 bn
South Korea's SK Ecoplant Co. has acquired Singapore-based electronic waste (e-waste) disposal and recycling company TES Envirocorp Pte. Ltd for $1 ...
Feb 21, 2022 (Gmt+09:00)
language -
Korean biotech startup signs license deal with US firm
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Feb 17, 2022 (Gmt+09:00)
-
IPOs
Hyundai Engineering drops IPO plan on stock market weakness
Hyundai Engineering Co., the plant engineering and construction unit of South Korea’s Hyundai Motor Group, dropped a listing plan to raise up ...
Jan 28, 2022 (Gmt+09:00)
-
Pharmaceuticals
ABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
-
Pharamaceuticals
SK Biopharm releases epilepsy treatment in UK
South Korean SK Biopharmaceuticals Co. launched its epilepsy treatment Cenobamate in the UK, rapidly expanding the company’s presence in Europ...
Dec 21, 2021 (Gmt+09:00)
-
Forbes taps MBK and Nexon founders as Asia's philanthropy heroes
Michael ByungJu Kim, the founder of South Korean investment firm MBK Partners, and Kim Jung-ju, founder of Nexon, the largest online gaming compan...
Dec 14, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to export COVID-19 treatment to Europe in 2021
South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...
Nov 30, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
Waste treatment
Hyundai Motor Group seeks to buy Korea waste treatment firm
Hyundai Engineering Co., Hyundai Motor Group’s construction arm, has joined the race to buy a South Korean garbage treatment company as the gr...
Nov 16, 2021 (Gmt+09:00)
-
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
Latest News
- 1 TheBorn Korea eyes M&As, overseas expansion after planned $73.7 million IPO
- 2 Korea's Hana Bank to promote foreigners as managers in overseas units
- 3 Samsung to unveil 400-layer bonding vertical NAND for AI servers by 2026
- 4 Korean LPs sharpen focus on GPs' post-investment management
- 5 LG Energy Q3 profit more than doubles on higher sales